AMBY J BINDRA

Allopathic & Osteopathic Physicians|Family Medicine DALLAS, TX NPI 1609831072

General Payments — all program years on this page

$905.63

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 55
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $348.23 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $348.2319

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $414.0428
2023 $143.368
2024 $348.2319

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086748991 Novartis Pharmaceuticals Corporation $19.09 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096652011 Novo Nordisk Inc $17.01 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097451668 Novo Nordisk Inc $18.71 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103328266 ABBVIE INC. $15.05 07/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104227237 AstraZeneca Pharmaceuticals LP $13.78 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105294361 AstraZeneca Pharmaceuticals LP $13.74 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105817087 AstraZeneca Pharmaceuticals LP $19.60 03/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116731482 GlaxoSmithKline, LLC. $16.43 09/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118078924 Boehringer Ingelheim Pharmaceuticals, Inc. $18.23 03/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118078926 Boehringer Ingelheim Pharmaceuticals, Inc. $20.36 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118862973 Otsuka America Pharmaceutical, Inc. $15.56 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118862975 Otsuka America Pharmaceutical, Inc. $19.71 09/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118862977 Otsuka America Pharmaceutical, Inc. $24.55 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136029299 Lilly USA, LLC $14.04 10/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136029301 Lilly USA, LLC $14.57 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136029353 Lilly USA, LLC $15.14 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136030420 Lilly USA, LLC $13.68 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136030422 Lilly USA, LLC $14.04 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144710832 Cleerly, Inc. $44.94 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.